Parkman Healthcare Partners’s QuidelOrtho QDEL Stock Holding History

Parkman Healthcare Partners’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.67M	Sell	101,764 -82,727	-45%	-$2.03M	0.17%	80
2025 Q4	$5.27M	Sell	184,491 -68,326	-27%	-$1.85M	0.5%	60
2025 Q3	$7.45M	Sell	252,817 -133,829	-35%	-$3.66M	0.78%	49
2025 Q2	$11.1M	Buy	386,646 +202,968	+111%	+$6M	1.28%	27
2025 Q1	$6.42M	Buy	183,678 +8,263	+5%	+$337K	0.76%	45
2024 Q4	$7.81M	Buy	175,415 +100,415	+134%	+$4.11M	1.04%	37
2024 Q3	$3.42M	Buy	+75,000	New	+$3.03M	0.44%	61
2020 Q4	–	Sell	-5,001	Closed	-$1.1M	–	94
2020 Q3	$1.1M	Sell	5,001 -999	-17%	-$223K	0.29%	70
2020 Q2	$1.34M	Buy	+6,000	New	+$940K	0.38%	65

Other funds holding QDEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Parkman Healthcare Partners's QDEL Position: Q1 2026 in Review

Parkman Healthcare Partners reduced its QuidelOrtho (QDEL) stake by 45% in Q1 2026, selling an estimated $2.03M and leaving 101,764 shares worth $1.67M. The position accounts for 0.17% of the portfolio, ranked #80.

Parkman Healthcare Partners first reported a position in QDEL in Q2 2020 and has held it in 9 quarters since. The position peaked at $11.1M in Q2 2025. 238 funds tracked by Wall St. Rank hold QDEL as of Q1 2026.

Parkman Healthcare Partners held 101,764 shares of QuidelOrtho worth $1.67M as of Q1 2026.
Parkman Healthcare Partners sold 82,727 QuidelOrtho shares in Q1 2026, an estimated $2.03M.
QuidelOrtho made up 0.17% of Parkman Healthcare Partners's portfolio in Q1 2026, its #80 holding.
Parkman Healthcare Partners first reported a position in QuidelOrtho in Q2 2020 and has held it in 9 quarters since.
Parkman Healthcare Partners's QuidelOrtho position peaked at $11.1M in Q2 2025.
238 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.